— Know what they know.
Not Investment Advice

AXGN NASDAQ

AxoGen, Inc.
1W: -13.8% 1M: -22.6% 3M: -18.7% YTD: +20.6% 1Y: +109.2% 3Y: +647.8% 5Y: +132.4%
$37.39
-2.53 (-6.34%)
 
Weekly Expected Move ±8.2%
$31 $34 $37 $40 $44
NASDAQ · Healthcare · Medical - Devices · Tech Score Sell · Power 36 · $2.0B mcap · 52M float · 2.35% daily turnover · Short 67% of daily vol

📊 Key Metrics

TTM
$251M
Revenue
+23.6% YoY
$-34M
Net Income
-619.5% YoY
$3M
Free Cash Flow
-40.7% YoY
72.7%
Gross Margin
-3.1%
Op. Margin
-2.2%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-18.2%
ROA-13.1%
ROIC-5.6%

Valuation

P/E-55.4
P/B7.8
EV/EBITDA-161.8

Leverage

Debt/Equity0.08
Current Ratio6.60
Interest Cov.-1.7x

Quality Scores

Piotroski F4/9
Altman Z30.17
Beneish M-2.87

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms